My Expertise
I have experience with accelerating the drug discovery process.
I understand the complexities and challenges that accompany the drug discovery and development process. As a scientific leader, leveraging data and advanced analytics to identify, develop, and patent new molecular entities is my specialty.
Led by founder and Principal Scientist Dr. Georgia McGaughey, my mission is helping your organization accelerate their drug discovery projects using innovative tools and advanced technologies, including machine learning, natural language processing (NLP), and artificial intelligence (AI), with impact from research to FDA approval.
My Areas of Expertise
While serving as an extension of your research department, I can provide expert guidance that encompasses all phases of the drug discovery and development process, from program strategy and computer-aided design to document filing and compound advancement.
My diverse team leadership experience includes gene identification, drug discovery regardless of modality, compound advancement (regulatory approval), toxicology informatics and image analysis, on/off target assessment, guide design (gene editing), and RNA/single cell sequencing analysis.
Results-driven Consulting Solutions for R&D Projects
At Trilligant, my clientele ranges from biotech start-ups and scientific institutions to investment firms.
My capabilities include:
- Computer-aided Drug Design
- ML Predictive Models
- Emerging Technologies
- Expert Witness
- Due Diligence